Caffeine-induced endothelial cell death and the inhibition of angiogenesis

Hua Li1, Sheng-Yu Jin, Hyun-Joon Son

  • 1Department of Anatomy, Chungbuk National University Medical School, Cheongju, Korea.

Insights

Caffeine inhibits blood vessel formation and human umbilical vein endothelial cell proliferation by inducing apoptosis. This effect is mediated by the adenosine A2B receptor and involves caspase-3 activation, impacting angiogenesis research.

Area of Science:

  • Cardiovascular Biology
  • Pharmacology
  • Cell Biology

Background:

  • Adenosine and its agonists are known to stimulate angiogenesis.
  • The impact of caffeine, an adenosine receptor antagonist, on angiogenesis remains uninvestigated.

Purpose of the Study:

  • To investigate the effect of caffeine on angiogenesis.
  • To elucidate the underlying mechanisms of caffeine's action on endothelial cells.

Main Methods:

  • Chick chorioallantoic membrane assays for angiogenesis.
  • Human umbilical vein endothelial cell (HUVEC) proliferation assays.
  • Western blotting, immunofluorescence, FACS, and DAPI staining for apoptosis and protein expression analysis.

Main Results:

  • Caffeine dose-dependently inhibited angiogenesis and HUVEC proliferation.
  • Caffeine induced HUVEC apoptosis and upregulated thrombospondin-1 (TSP-1) via the adenosine A2B receptor.
  • Caffeine modulated caspase-3 and Bcl-2 protein levels, suggesting a caspase-3 dependent apoptotic pathway.

Conclusions:

  • Caffeine inhibits angiogenesis by inducing endothelial cell apoptosis.
  • The mechanism involves TSP-1 upregulation and caspase-3 activation, mediated by the adenosine A2B receptor.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...